Cargando…

Dual mechanism of Let-7i in tumor progression

Let-7i regulates tumors primarily by binding to the 3′ untranslated region (3′ UTR) of mRNA, which indirectly regulates post-transcriptional gene expression. Let-7i also has an epigenetic function via modulating DNA methylation to directly regulate gene expression. Let-7i performs a dual role by ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jiapei, Xiang, Hongjie, Cao, Zhiqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565035/
https://www.ncbi.nlm.nih.gov/pubmed/37829341
http://dx.doi.org/10.3389/fonc.2023.1253191
_version_ 1785118608586702848
author Zhou, Jiapei
Xiang, Hongjie
Cao, Zhiqun
author_facet Zhou, Jiapei
Xiang, Hongjie
Cao, Zhiqun
author_sort Zhou, Jiapei
collection PubMed
description Let-7i regulates tumors primarily by binding to the 3′ untranslated region (3′ UTR) of mRNA, which indirectly regulates post-transcriptional gene expression. Let-7i also has an epigenetic function via modulating DNA methylation to directly regulate gene expression. Let-7i performs a dual role by inducing both the promotion and inhibition of various malignancies, depending on its target. The mechanism of Let-7i action involves cancer cell proliferation, migration, invasion, apoptosis, epithelial-mesenchymal transition, EV transmission, angiogenesis, autophagy, and drug resistance sensitization. Let-7i is closely related to cancer, and hence, is a potential biomarker for the diagnosis and prognosis of various cancers. Therapeutically, it can be used to promote an anti-cancer immune response by modifying exosomes, thus exerting a tumor-suppressive effect.
format Online
Article
Text
id pubmed-10565035
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105650352023-10-12 Dual mechanism of Let-7i in tumor progression Zhou, Jiapei Xiang, Hongjie Cao, Zhiqun Front Oncol Oncology Let-7i regulates tumors primarily by binding to the 3′ untranslated region (3′ UTR) of mRNA, which indirectly regulates post-transcriptional gene expression. Let-7i also has an epigenetic function via modulating DNA methylation to directly regulate gene expression. Let-7i performs a dual role by inducing both the promotion and inhibition of various malignancies, depending on its target. The mechanism of Let-7i action involves cancer cell proliferation, migration, invasion, apoptosis, epithelial-mesenchymal transition, EV transmission, angiogenesis, autophagy, and drug resistance sensitization. Let-7i is closely related to cancer, and hence, is a potential biomarker for the diagnosis and prognosis of various cancers. Therapeutically, it can be used to promote an anti-cancer immune response by modifying exosomes, thus exerting a tumor-suppressive effect. Frontiers Media S.A. 2023-09-27 /pmc/articles/PMC10565035/ /pubmed/37829341 http://dx.doi.org/10.3389/fonc.2023.1253191 Text en Copyright © 2023 Zhou, Xiang and Cao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhou, Jiapei
Xiang, Hongjie
Cao, Zhiqun
Dual mechanism of Let-7i in tumor progression
title Dual mechanism of Let-7i in tumor progression
title_full Dual mechanism of Let-7i in tumor progression
title_fullStr Dual mechanism of Let-7i in tumor progression
title_full_unstemmed Dual mechanism of Let-7i in tumor progression
title_short Dual mechanism of Let-7i in tumor progression
title_sort dual mechanism of let-7i in tumor progression
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565035/
https://www.ncbi.nlm.nih.gov/pubmed/37829341
http://dx.doi.org/10.3389/fonc.2023.1253191
work_keys_str_mv AT zhoujiapei dualmechanismoflet7iintumorprogression
AT xianghongjie dualmechanismoflet7iintumorprogression
AT caozhiqun dualmechanismoflet7iintumorprogression